key: cord-0864824-8ak30s2o
authors: Stevanović, Vedran; Ljubas, Dominik; Krmek, Nikola; Kniewald, Hrvoje; Marić, Lorna Stemberger; Roglić, Srđan; Tešović, Goran
title: Mobitz Type I as the Initial Presentation of Multisystem Inflammatory Syndrome in Children
date: 2022-02-08
journal: Pediatr Infect Dis J
DOI: 10.1097/inf.0000000000003468
sha: a7006665857e16a6b7f8adcc0e57f2b38acf6fe9
doc_id: 864824
cord_uid: 8ak30s2o

nan

Since the emergence of the novel coronavirus SARS-CoV-2, great attention was drawn to the multisystem inflammatory syndrome in children (MIS-C) -a life-threatening complication. Although conduction disorders are uncommon in childhood, a growing number of mild cases address these abnormalities with MIS-C. 1 Usually they include prolonged QTc interval, first-degree atrioventricular block (AVB), right bundle branch block, ST-segment changes and tachyarrhythmias. 1 This report illustrates the importance of cardiovascular monitoring in patients with MIS-C admitted to the pediatric intensive care unit (PICU).

A previously healthy 9-year-old boy presented with a high fever of 39.4°C and vomiting lasting for 4 days. He tested positive for SARS-CoV-2 by RT-PCR from a nasopharyngeal swab. On physical examination, the patient was hypotensive (blood pressure of 90/50 mm Hg) and tachycardic (heart rate of 103 beats per minute).

Initial laboratory tests revealed a WBC count of 6.3 × 10 9 /L with relative neutrophilia (85%), elevated inflammatory markers (procalcitonin of 0.949 mcg/L, C-reactive protein of 165.6 mg/L, ferritin of 280.3 mcg/L, interleukin-6 of 352.8 ng/L, fibrinogen of 7.6 g/L and D-dimers of 4.45 mg/L) and elevated cardiac markers (troponin of 0.970 mcg/L and NT-pro-BNP of 6092 ng/L). Upon sudden development of bradycardia (heart rate of 45 beats per minute), electrocardiogram (ECG) revealed Mobitz type I second-degree AVB. Echocardiography documented moderate mitral regurgitation and normal left ventricular ejection fraction without pericardial effusion.

Treatment in the PICU included empiric antimicrobial therapy with ceftriaxone and clindamycin, intravenous immunoglobulins, glucocorticoids, vasopressor support and diuretics. The fever receded after 7 days. The blood cultures were negative. However, ECG raised suspicion of possible progression to more advanced blocks with a P:QRS ratio of 3:1 while the cardiac markers were still elevated (troponin of 0.062 mcg/L and NT-pro-BNP of 4110 ng/L). Serial ECG revealed spontaneous conversion to normal sinus rhythm within 3 days, confirmed by the 24-hour ECG monitoring. The patient was discharged after 14 days. At the 3-and 6-months follow-up, a 24-hour ECG recording and ergometric testing showed normal rhythm without any signs of AVB.

Mobitz type I second-degree AVB secondary to MIS-C is clinically difficult to recognize due to the predominant development of hypotension and tachycardia upon admission, whereas low and irregular heart rate would be indicative of such conduction disorder in a child without MIS-C. 2 Several studies explored acute cardiovascular manifestations in MIS-C where Valverde et al included 286 cases and Regan et al described serial ECGs in 63 cases with a median of 5 ECGs per patient. 1, 3 Neither study reported a second-degree AVB. All patients with severe MIS-C require PICU admission due to possible rapid hemodynamic deterioration. Furthermore, all patients with Mobitz type I second-degree AVB should be admitted and monitored due to possible progression to bradycardia, hypotension and/or higher degree AVB. 2 In conclusion, MIS-C cases started having unique presentations, including cardiac conduction disorders. Second-degree AVB can be a presenting finding of MIS-C and high clinical suspicion must be held for patients presenting with signs of shock.

Electrocardiographic changes in children with multisystem inflammation associated with COVID-19: associated with Coronavirus Disease

Atrioventricular block second-degree

AEPC COVID-19 Rapid Response Team*. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe